1. Davies H. Catheter mounted valve for temporary relief of aortic insufficiency. Lancet 1965; 1.
2. Moulopoulos SD, Anthopoulos L, Stamatelopoulos S, Stefadouros M. Catheter-mounted aortic valves. Ann Thorac Surg 1971; 11: 423–30.
3. Phillips SJ, Ciborski M, Freed PS et al. A temporary catheter-tip aortic valve: hemodynamic effects on experimental acute aortic insufficiency. Ann Thorac Surg 1976; 21: 134–7.
4. Matsubara T, Yamazoe M, Tamura Y et al. Balloon catheter with check valves for experimental relief of acute aortic regurgitation. Am Heart J 1992; 124: 1002–8.
5. Cribier A, Savin T, Saoudi N et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1986; 1: 63–7.
6. Drobinski G, Lechat P, Metzger JP et al. Results of percutaneous catheter valvuloplasty for calcified aortic stenosis in the elderly. Eur Heart J 1987; 8: 322–8.
7. Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994; 89: 642–50.
8. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006–8.
9. Cribier A, Eltchaninoff H, Tron C et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006; 47: 1214–23.
10. Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113: 842–50.
11. De Jaegere P, van Dijk LC, Laborde JC et al. True percutaneous implantation of the Core Valve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar XL and the Tandem Heart. EuroIntervention 2007; 2: 500–5.
12. O’Brien SM, Shahian DM, Filardo G et al. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009; 88: S23–42.
13. Nashef SA, Roques F, Michel P et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9–13.
14. Buellesfeld L, Gerckens U, Schuler G et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 2011; 57: 1650–7.
15. Delgado V, Ewe SH, Ng AC et al. Multimodality imaging in transcatheter aortic valve implantation: key steps to assess procedural feasibility. EuroIntervention 2010; 6: 643–52.
16. Piazza N, de Jaegere P, Manoharan G et al. Patient Selection for the CoreValve ReValving System. In: Serruys P, Piazza N, Cribier A et al. Transcatheter aortic valve implantation: Tips and tricks to avoid failure. New York: Informa Healthcare 2011; 82.
17. Piazza N, Serruys PW, Lange R. Getting safely in and out of a transcatheter aortic valve implantation procedure vascular complications according to the valvular academic research consortium criteria. JACC Cardiovasc Interv 2011; 4: 859–60.
18. Petronio AS, de Carlo M, Bedogni F et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010; 3: 359–66.
19. Guarracino F, Covello RD, Landoni G et al. Anesthetic management of transcatheter aortic valve implantation with transaxillary approach. J Cardiothorac Vasc Anesth 2011; 25: 437–43.
20. Kempfert J, Rastan A, Holzhey D et al. Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients. Circulation 2011; 124: S124–9.
21. Kempfert J, Rastan AJ, Mohr FW, Walther T. A new self-expanding transcatheter aortic valve for transapical implantation – first in man implantation of the JenaValve. Eur J Cardiothorac Surg 2011; 40: 761–3.
22. Bapat V, Thomas M, Hancock J, Wilson K. First successful trans-catheter aortic valve implantation through ascending aorta using Edwards SAPIEN THV system. Eur J Cardiothorac Surg 2010; 38: 811–3.  
23. Cockburn J, Trivedi U, Hildick-Smith D. Transaortic transcatheter aortic valve implantation within a previous bioprosthetic aortic valve replacement. Catheter Cardiovasc Interv 2011; 78: 479–84.
24. Piazza N, de Jaegere P, Schultz C et al. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 2008; 1: 74–81.
25. Schultz CJ, Moelker A, Piazza N et al. Three dimensional evaluation of the aortic annulus using multislice computer tomography: are manufacturer’s guidelines for sizing for percutaneous aortic valve replacement helpful? Eur Heart J 2009.
26. Tops LF, Wood DA, Delgado V et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2008; 1: 321–30.
27. Ng AC, Yiu KH, Ewe SH et al. Influence of left ventricular geometry and function on aortic annular dimensions as assessed with multi-detector row computed tomography: implications for transcatheter aortic valve implantation. Eur Heart J 2011; 32: 2806–13.
28. Schultz C, Moelker A, Tzikas A et al. The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach. EuroIntervention 2010; 6: 505–11.
29. Schultz CJ, Moelker AD, Tzikas A et al. Cardiac CT: necessary for precise sizing for transcatheter aortic implantation. EuroIntervention 2010; (6 Suppl. G): G6–G13.
30. Nietlispach F, Wijesinghe N, Wood D et al. Current balloon-expandable transcatheter heart valve and delivery systems. Catheter Cardiovasc Interv 2010; 75: 295–300.
31. Rodes-Cabau J, Delarochelliere R, Dumont E. First-in-man transcatheter aortic valve implantation of a 20-mm edwards SAPIEN XT valve: One step forward for the treatment of patients with severe aortic stenosis and small aortic annulus. Catheter Cardiovasc Interv 2011.
32. Mussardo M, Latib A, Chieffo A et al. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC Cardiovasc Interv 2011; 4: 743–50.
33. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 1994; 90: 323–9.
34. Vavuranakis M, Vrachatis DA, Toutouzas K et al. Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access. Heart Vessels 2010; 25: 359–62.
35. Munoz-Garcia AJ, Alonso-Briales JH, Such-Martinez M, Hernandez-Garcia JM. Left subclavian artery approach to CoreValve aortic prosthesis implantation. Rev Esp Cardiol 2010; 63: 121–2.
36. Ruge H, Lange R, Bleiziffer S et al. First successful aortic valve implantation with the CoreValve ReValving System via right subclavian artery access: a case report. Heart Surg Forum 2008; 11: E323–4.
37. Moynagh AM, Scott DJ, Baumbach A et al. UK CoreValve Collaborative. CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach. J Am Coll Cardiol 2011; 57: 634–5.
38. Mouillet G, Desgranges P, Teiger E. Transcatheter aortic valve implantation when classical access routes are unavailable. Catheter Cardiovasc Interv 2011; 78: 1004–7.
39. Sarkar K, Ussia GP, Tamburino C. Transcatheter aortic valve implantation for severe aortic regurgitation in a stentless bioprosthetic valve with the core valve revalving system-technical tips and role of the Accutrak system. Catheter Cardiovasc Interv 2011; 78: 485–90.
40. Fassl J, Walther T, Groesdonk HV et al. Anesthesia management for transapical transcatheter aortic valve implantation: a case series. J Cardiothorac Vasc Anesth 2009; 23: 286–91.
41. Cockburn J, de Belder A, Brooks M et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the prostar system in 118 cases. Catheter Cardiovasc Interv 2011.
42. Kahlert P, Eggebrecht H, Erbel R, Sack S. A modified preclosure technique after percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2008; 72: 877–84.
43. Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011; 32: 205–17.
44. Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011; 57: 253–69.
45. Piazza N, Cutlip DE, Onuma Y et al. Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions. EuroIntervention 2009; 5: 29–31.
46. Piazza N, Onuma Y, de Jaegere P, Serruys PW. Guidelines for reporting mortality and morbidity after cardiac valve interventions – need for a reappraisal? Ann Thorac Surg 2009; 87: 357–8; discussion 359–60.
47. Thomas M, Wendler O. Transcatheter aortic valve implantation (TAVI): how to interpret the data and what data is required? EuroIntervention 2009; 5: 25–7.
48. Haworth P, Behan M, Khawaja M et al. Predictors for permanent pacing after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76: 751–6.
49. Abdel-Wahab M, Zahn R, Horack M et al. German transcatheter aortic valve interventions registry investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 2011; 97: 899–906.
50. Bleiziffer S, Ruge H, Hörer J et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010; 3: 524–30.
51. Motloch LJ, Reda S, Rottlaender D et al. Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg 2012; 93: 124–31.
52. Saia F, Marrozzini C, Marzocchi A. Displacement of calcium nodules of the native valve as a possible cause of left main occlusion following transcatheter aortic valve implantation. J Invasive Cardiol 2011; 23: E106–9.
53. Bartorelli AL, Andreini D, Sisillo E et al. Left main coronary artery occlusion after percutaneous aortic valve implantation. Ann Thorac Surg 2010; 89: 953–5.
54. Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755–63.
55. Virmani R, Bonan R, Nakazawa G et al. Accumulation of worldwide experience with postmortem studies of transcatheter aortic valve implantation – what should we be avoiding? In: Serruys P, Piazza N, Cribier A et al. Transcatheter aortic valve implantation: Tips and tricks to avoid failure. New York: Informa Healthcare 2011: 18–39.

С.П.Семитко 

Кафедра рентгенхирургических методов диагностики и лечения ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ, Москва